Rare Disease Day at NIH 2019

Rare Disease Day® takes place worldwide, typically on or near the last day of February each year, to raise awareness among policymakers and the public about rare diseases and their impact on patients’ lives. Each year, NCATS and the NIH Clinical Center (CC) sponsor Rare Disease Day at NIH as part of this global observance. This year’s global theme is “bridging health and social care.”

2019 Event Information

Rare Disease Day logo

Thursday, Feb. 28, 2019
8:30 a.m.-4:00 p.m. ET
Main Auditorium, Natcher Conference Center, Building 45*
National Institutes of Health
Bethesda, Maryland

*Note new, bigger location for 2019!

Sponsored by NCATS and the CC, this year’s event will feature interactive panel discussions on collective research models for rare diseases, patient registries, rare cancer research initiatives, and "no disease left behind, no patient left behind." New this year will be a presentation of the first ever Zebbie award for the NCATS Rare Diseases are Not Rare! Challenge. Other highlights include posters and exhibits by rare disease groups and researchers as well as artwork, videos and CC tours. Admission is free and open to the public. In association with Global Genes®, participants are encouraged to wear their favorite pair of jeans. Be sure to follow the event on social media using #RDDNIH.

Website • Tentative Agenda • Register • Poster/Exhibit Information

About Rare Disease Day

Poster presenters at Rare Disease Day at NIH 2018.

Poster presenters at Rare Disease Day at NIH 2018. (Daniel Soñé Photography)

EURORDIS sponsored the first Rare Disease Day in Europe on Feb. 29, 2008. The United States joined the first global observance the following year along with 23 other countries. Visit Rare Disease Day USA and International Rare Disease Day for more information.

About Rare Disease Day at NIH

Each year, the slogan for NIH’s event has been “Patients & Researchers — Partners for Life.” This slogan aligns with NCATS’ philosophy that researchers must work closely with patients, families, caregivers and advocacy groups to maximize the chances for success in advancing rare diseases research. This philosophy has been put into practice in NCATS’ Toolkit for Patient-Focused Therapy Development, Rare Diseases Clinical Research NetworkTherapeutics for Rare and Neglected Diseases program, and Genetic and Rare Diseases Information Center, among other efforts.

The goals of Rare Disease Day at NIH are to:

  • Demonstrate the NIH commitment to helping people with rare diseases through research;
  • Highlight NIH-supported rare diseases research and the development of diagnostics and treatments;
  • Initiate a mutually beneficial dialogue among public and private researchers, patients, patient advocates and policymakers;
  • Exchange the latest rare diseases information with stakeholders to advance research and therapeutic efforts; and
  • Put a face on rare diseases by sharing stories of patients, their families and their communities.

Learn more about past Rare Disease Day at NIH events.

NCATS and Rare Diseases Research

Poster presenters at Rare Disease Day at NIH 2018.

Poster presenters at Rare Disease Day at NIH 2018. (Daniel Soñé Photography)

About 7,000 rare diseases affect humans, of which only a few hundred have any treatment. Although each rare disease affects fewer than 200,000 Americans, in total, these illnesses affect an estimated 30 million people in the United States. Since rare diseases often are difficult to diagnose, it can take years to obtain an accurate diagnosis. Even after a proper diagnosis, treatment often is unavailable, because only about 5 percent of rare diseases have a treatment approved by the Food and Drug Administration.

As a result, rare diseases are devastating and costly for patients, their families and the nation as a whole. Most rare diseases are serious or life-threatening, chronic and progressive disorders that place substantial medical and financial burdens on patients and their families.

Through its work to improve health through smarter science, NCATS supports collaborative and innovative approaches to research on rare diseases. These efforts have the potential to speed development of treatments for multiple rare diseases and ultimately help more patients more quickly.